3972
S. I. Kozhushkov et al.
PRACTICAL SYNTHETIC PROCEDURES
3-{1-(9H-Fluoren-9-yl)methoxycarbonylamino]cyclopro-
pyl}propiolic Acid (13)
B: Org. Chem. Incl. Med. Chem. 1977, 15, 133. (g) Aoyagi,
E. I. US Patent 4271306, 1981; Chem. Abstr. 1981, 95:
97786.
Et3N (3.05 g, 4.2 mL, 30.2 mmol) was added dropwise to an ice-
cooled solution of N-(9-fluorenylmethoxycarbonyloxy)succinimide
(Fmoc-OSu) (6.06 g, 18.0 mmol), and the amino acid hydrochloride
4·HCl (2.12 g, 14.4 mmol) in a mixture of MeOH (100 mL) and
CH2Cl2 (100 mL) was then added at 0 °C over a period of 0.5 h. The
reaction mixture was allowed to warm up to 20 °C overnight, and
the solvents were evaporated. The residue was taken up with a H2O–
Et2O mixture (100 + 100 mL), acidified by adding 1 N aq HCl so-
lution (35 mL) and the mixture immediately extracted with Et2O
(3 × 100 mL). The combined organic layers were dried and concen-
trated under reduced pressure. The residue was stirred with a hot
hexane–THF mixture (80 + 5 mol) for 5 min and then kept at –20 °C
overnight to yield 4.11 g (81%) of the pure compound 13 as a col-
orless solid, which is poorly soluble in CDCl3; mp 181–183 °C
(dec.).
(8) For peptidomimetics containing 1-aminocyclopropane-
carboxylic acid (ACC) residues, see: Brackmann, F.;
de Meijere, A. Chem. Rev. 2007, 107, 4493; and references
cited therein.
(9) See, for example: (a) Mertin, A.; Thiemann, T.; Hanss, I.;
de Meijere, A. Synlett 1991, 87. (b) Liu, J.; An, Y.; Jiang,
H.-Y.; Chen, Z. Tetrahedron Lett. 2008, 49, 490.
(c) Bieraugel, H.; Akkerman, J. M.; Lapierre Armande, J. C.;
Pandit, U. K. Recl. Trav. Chim. Pays-Bas 1976, 95, 266.
(d) Liese, T.; de Meijere, A. Chem. Ber. 1986, 119, 2995.
(e) Shavrin, K. N.; Gvozdev, V. D.; Budanov, D. V.; Yurov,
S. V.; Nefedov, O. M. Mendeleev Commun. 2006, 73.
(10) Marstokk, K.-M.; de Meijere, A.; Wagner-Gillen, K.;
Møllendal, H. J. Mol. Struct. 1999, 509, 1.
(11) See, for example: (a) Moser, H.; Lu, Q.; Patten, P. A.;
Wang, D.; Kasar, R.; Kaldor, S.; Patterson, B. D. Patent WO
2008154642 A2, 2008; Chem. Abstr. 2008, 150, 56532.
(b) Letrent, S. P. Patent WO 2006129163 A1, 2006; Chem.
Abstr. 2006, 146, 39020. (c) Connell, R. D.; Denis, L. J.;
Jani, J. P. US Patent 2005101618 A1, 2005; Chem. Abstr.
2005, 142, 441833. (d) Kath, J. C.; Bhattacharya, S. K.;
Morris, J. Patent WO 2001098277 A2, 2001; Chem. Abstr.
2001, 136, 69816. (e) Sendzik, M. Patent WO 2005019174
A1, 2005; Chem. Abstr. 2005, 142, 280045.
1H NMR (250 MHz, THF-d8): d = 7.79–7.62 (m, 4 H), 7.37–7.25
(m, 5 H), 4.43–4.30 (m, 2 H), 4.19 (m s, 1 H), 1.30–1.13 (m
AA¢BB¢, 4 H, cyclopropane CH2).
13C NMR (62.9 MHz, THF-d8): d = 156.5 (C), 154.3 (C), 145.2 (2
C), 142.3 (2 C), 128.3 (2 CH), 127.8 (2 CH), 125.9 (2 CH), 120.6 (2
CH), 90.3 (C), 72.5 (C), 66.8 (CH2), 48.2 (CH), 24.1 (C), 19.0 (2
CH2).
HRMS (ESI): m/z [M + Na]+ calcd for C21H17NO4 + Na: 370.1055;
found: 370.1050.
(12) (a) Takemura, M.; Kimura, Y.; Takahashi, H.; Kimura, K.;
Miyauchi, S.; Ohki, H.; Sugita, K.; Miyauchi, R. US Patent
6121285 A, 2000; Chem. Abstr. 2000, 133, 237871.
(b) Takemura, M.; Takahashi, H.; Sugita, K.; Ohki, H.;
Miyauchi, S.; Miyauchi, R. Patent WO 9852939 A1, 1998;
Chem. Abstr. 1998, 130, 13992.
(13) For a review, see: Knorr, R. Chem. Rev. 2004, 104, 3795.
(14) (a) Kimura, Y.; Atarashi, S.; Takahashi, M.; Hayakawa, I.
Chem. Pharm. Bull. 1994, 42, 1442. (b) Schroeder, M. C.;
Kiely, J. S. J. Heterocycl. Chem. 1988, 25, 1769.
(c) Graupe, M.; Link, J. O.; Röpel, M. G. Patent WO
2006102243 A2, 1996; Chem. Abstr. 1996, 145, 357108.
(d) Link, J. O. Patent WO 2006102423 A1, 2006; Chem.
Abstr. 2006, 145, 377571.
(15) (a) Corley, E. G.; Thompson, A. S.; Huntington, M. Org.
Synth. 2000, 77, 231. (b) Militzer, H. C.; Schömenauer, S.;
Otte, C.; Puls, C.; Hain, J.; Bräse, S.; de Meijere, A.
Synthesis 1993, 998. (c) Wang, Z.; Campagna, S.; Yang, K.;
Xu, G.; Pierce, M. E.; Fortunak, J. M.; Confalone, P. N.
J. Org. Chem. 2000, 65, 1889. (d) Schmidt, S. E.; Salvatore,
R. N.; Jung, K. W.; Kwon, T. Synlett 1999, 1948.
(e) Henningsen, M.; Stamm, A.; Fischer, M.; Siegel, W.
German Patent DE 19709401 A1, 1998; Chem. Abstr. 1998,
129, 202703. (f) Gandy, R.; Cremins, P. J.; Timms, A. W.
British Patent GB 2329384 A, 1999; Chem. Abstr. 1999,
130, 324960.
References
(1) (a) Cyclopropyl Building Blocks for Organic Synthesis, 157.
For Part 156, see: de Meijere, A.; Chaplinski, V.; Winsel, H.;
Kordes, M.; Stecker, B.; Gazizova, V.; Savchenko, A. I.;
Schill, F. Chem. Eur. J. 2010, in press; DOI: 10.1002/
chem.201001550. (b) For Part 155, see: Lygin, A.; Limbach,
M.; Janssen, A.; Korotkov, V. S.; Funke, C.; de Meijere, A.
Eur. J. Org. Chem. 2010, 3665.
(2) (a) Wuitschik, G.; Rogers-Evans, M.; Müller, K.; Fischer,
H.; Wagner, B.; Schuler, F.; Polonchuk, L.; Carreira, E. M.
Angew. Chem. Int. Ed. 2006, 45, 7736; Angew. Chem. 2006,
118, 7900. (b) Wuitschik, G.; Rogers-Evans, M.; Buckl, A.;
Bernasconi, M.; Märki, M.; Godel, T.; Fischer, H.; Wagner,
B.; Parrilla, I.; Schuler, F.; Schneider, J.; Alker, A.;
Schweizer, W. B.; Müller, K.; Carreira, E. M. Angew. Chem.
Int. Ed. 2008, 47, 4512; Angew. Chem. 2008, 120, 4588.
(3) For example, for spirocyclopropane analogues of penicillins
and cephalosporins, see the review: Brackmann, F.;
de Meijere, A. Chem. Rev. 2007, 107, 4538; and references
cited therein.
(4) The steric effect of a cyclopropyl group is rather well
accounted for by the set of S f(R) values: Beckhaus, H. D.
Angew. Chem., Int. Ed. Engl. 1978, 17, 593; Angew. Chem.
1978, 90, 633: S f(R) = 0.00 (Me), 0.86 (Et), 1.33
(cyclopropyl), 1.81 (cyclopentyl), 2.29 (i-Pr), 3.82 (t-Bu).
(5) See, for example: Wiberg, K. B. Introduction In Methods of
Organic Chemistry (Houben-Weyl), Vol. E 17a; de Meijere,
A., Ed.; Thieme: Stuttgart, 1997, 1.
(16) Miller, R. B.; McGarvey, G. J. Org. Chem. 1978, 43, 4424.
(17) For an alternative synthesis of 7 from trimethylsilyl-
acetylene, see ref. 15b.
(18) (a) de Meijere, A.; Kozhushkov, S. I.; Haumann, T.; Boese,
R.; Puls, C.; Cooney, M. J.; Scott, L. T. Chem. Eur. J. 1995,
1, 124. (b) de Meijere, A.; Kozhushkov, S. I. Chem. Eur. J.
2002, 8, 3195.
(6) Hamzik, P. J.; Brubaker, J. D. Org. Lett. 2010, 12, 1116.
(7) (a) Urleb, U.; Neidlein, R.; Kramer, W. Helv. Chim. Acta
1993, 76, 431. (b) Reisch, J.; Usifoh, C. O.; Oluwadiya, J. O.
J. Heterocycl. Chem. 1989, 26, 1495. (c) Luedtke, A.;
Meng, K.; Timberlake, J. W. Tetrahedron Lett. 1987, 28,
4255. (d) Klein, C. L.; Majeste, R. J.; Luedtke, A. E.; Ray,
W. J. Jr.; Stevens, E. D.; Timberlake, J. W. J. Org. Chem.
1984, 49, 1208. (e) Chiu, S.-K.; Keifer, L.; Timberlake, J.
W. J. Med. Chem. 1979, 22, 746. (f) Arya, V. P.; Grewal, R.
S.; Kaul, C. L.; David, J.; Honkan, V. Indian J. Chem., Sect.
(19) (a) Weinstock, J. J. Org. Chem. 1961, 26, 3511.
(b) Jandralla, H. Chem. Ber. 1980, 113, 3585.
(20) Brandl, M.; Kozhushkov, S. I.; Yufit, D. S.; Howard, J. A.
K.; de Meijere, A. Eur. J. Org. Chem. 1998, 2785.
(21) The procedure was adapted from the supporting information
associated with: Hornberger, K. R.; Hamblett, C. L.;
Leighton, J. L. J. Am. Chem. Soc. 2000, 122, 12894.
Synthesis 2010, No. 23, 3967–3973 © Thieme Stuttgart · New York